Quantcast

Latest Healthcare in India Stories

2010-06-04 06:30:00

CALGARY, June 4 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that Dr. Brad Thompson, President and CEO, will host a conference call and webcast on Monday, June 7th, 2010 at 7:00 a.m. MT (9:00 a.m. ET) to discuss the Phase I/II head and neck cancer data being presented that day at the ASCO Annual Meeting in Chicago, IL. To access the conference call by telephone, dial 1-647-427-7450 or 1-888-231-8191. A live audio webcast will also be...

2010-06-03 06:30:00

CALGARY, June 3 /PRNewswire-FirstCall/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will present a corporate overview of the Company at the 9th Annual Needham Healthcare Conference on Wednesday, June 9th, 2010 at 2:00 p.m. EDT. The conference takes place June 9th and 10th 2010 at the New York Palace Hotel. A live audio link to the webcast presentation is available at: http://www.wsw.com/webcast/needham38/oncy/ or on the company's website at...

2010-05-10 15:50:00

NEW YORK, May 10 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of life-threatening diseases, including cancer and renal disease (the "Company"), today announced its results for the first quarter ended March 31, 2010. At March 31, 2010, the Company had cash, cash equivalents, interest receivable, and investment...

2010-05-10 07:00:00

SAN DIEGO, May 10 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company's Chief Executive Officer, Brian M. Culley, will present at the Rodman & Renshaw Annual Global Investment Conference on Monday, May 17, 2010, at 11:05 a.m. local time (6:05 a.m. Eastern time), in the Albemarle Suite at the Grosvenor House Hotel in London. Interested parties can access a live audio webcast and slide presentation on the ADVENTRX Pharmaceuticals Web...

2010-05-07 06:30:00

CALGARY, May 7 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that its 2010 Annual and Special Meeting of the Shareholders will be held on Tuesday, May 11, 2010 at 4:30 p.m. Eastern Time at the Hilton Toronto Hotel, 145 Richmond Street West, Toronto, Ontario. Following the business portion of the meeting, Dr. Brad Thompson, President and CEO of Oncolytics, will discuss recent progress in the development of REOLYSIN(R) as a potential cancer...

2010-05-05 16:22:00

CAMBRIDGE, Mass., May 5 /PRNewswire/ -- Abt Associates announced today the sale of its wholly-owned subsidiary Abt Bio-Pharma Solutions, Inc. (ABS) to United BioSource Corporation (UBC), a global scientific and medical affairs organization that partners with life science companies to develop and commercialize biopharmaceuticals, medical devices, and other health care technologies. The addition of ABS scientists and resources establishes UBC with the largest presence and operational reach...

2010-05-03 09:11:00

SAN FRANCISCO, May 3 /PRNewswire/ -- Despite the pop in the shares of Dendreon on the announcement that its prostate cancer therapy Provenge had finally been approved by the FDA, the biotech sector failed to build on that event and turned in a lackluster performance for the month with the Burrill Biotech Select Index dropping 2 percent in April. Not helping the cause was the fact that several companies including Amgen and Gilead Sciences cut their profit forecasts citing the impact of costs...

2010-04-29 07:00:00

LEWISBERRY, Pa., April 29 /PRNewswire-FirstCall/ -- Unilife Corporation ("Unilife" or "Company") (Nasdaq: UNIS; ASX: UNS), a leading developer of safety medical devices, today announced its entry into the Indian market to help support efforts by the Central Government of India and international agencies to institute the mandatory use of safety syringes within local healthcare facilities. Dr. Gerald Verollet, Vice-President of Scientific and International Affairs, has relocated to India...

2010-04-13 08:00:00

ST. LOUIS, April 13 /PRNewswire-FirstCall/ -- K-V Pharmaceutical Company (NYSE: KVa/KVb) (the "Company") today announced it has appointed Stephen A. Stamp as Chief Financial Officer and Treasurer, effective April 7, 2010. Mr. Stamp will report directly to David Van Vliet, interim CEO of the Company. David Van Vliet, interim CEO of the Company stated, "Stephen brings decades of financial experience and deep healthcare industry knowledge to K-V and we are excited to welcome him aboard. We...

2010-04-06 08:00:00

SAN FRANCISCO, April 6, 2010 /PRNewswire/ -- Germany is ranked number one in exporting research-intensive goods. This level of innovation drives the world's second largest market for biotechnology after the United States. Germany Trade & Invest will have representatives at this year's BayBio 2010 conference on April 7 in San Francisco, California, to highlight opportunities for American companies in Germany. There are more companies operating in the biotech and biomedical...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related